Selectively targeting pain in the trigeminal system
We tested whether it is possible to selectively block pain signals in the orofacial area by
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
Selectively targeting pain in the trigeminal system
HY Kim, K Kim, HY Li, G Chung, CK Park, JS Kim… - PAIN, 2010 - scholarworks.bwise.kr
We tested whether it is possible to selectively block pain signals in the orofacial area by
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
Selectively targeting pain in the trigeminal system
HY Kim, K Kim, HY Li, G Chung, CK Park, JS Kim… - Pain, 2010 - snusci.elsevierpure.com
We tested whether it is possible to selectively block pain signals in the orofacial area by
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
Selectively targeting pain in the trigeminal system.
HY Kim, K Kim, HY Li, G Chung, CK Park, JS Kim… - Pain, 2010 - europepmc.org
We tested whether it is possible to selectively block pain signals in the orofacial area by
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
Selectively targeting pain in the trigeminal system
HY Kim, K Kim, HY Li, G Chung, CK Park, JS Kim… - Pain, 2010 - infona.pl
We tested whether it is possible to selectively block pain signals in the orofacial area by
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
Selectively targeting pain in the trigeminal system
HY Kim, K Kim, HY Li, G Chung, CK Park, JS Kim… - Pain, 2010 - pubmed.ncbi.nlm.nih.gov
We tested whether it is possible to selectively block pain signals in the orofacial area by
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
[PDF][PDF] Selectively targeting pain in the trigeminal system
HY Kim, K Kim, HY Li, G Chung, CK Park, JS Kim… - 2010 - academia.edu
abstract We tested whether it is possible to selectively block pain signals in the orofacial
area by delivering the permanently charged lidocaine derivative QX-314 into nociceptors via …
area by delivering the permanently charged lidocaine derivative QX-314 into nociceptors via …
[引用][C] Selectively targeting pain in the trigeminal system
HY Kim, K Kim, HY Li, G Chung, CK Park, JS Kim… - Pain, 2010 - cir.nii.ac.jp
Selectively targeting pain in the trigeminal system
HY Kim, K Kim, HY Li, G Chung, CK Park, JS Kim… - PAIN, 2010 - journals.lww.com
We tested whether it is possible to selectively block pain signals in the orofacial area by
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
[HTML][HTML] Selectively targeting pain in the trigeminal system
HY Kim, K Kim, HY Li, G Chung, CK Park, JS Kim… - Pain, 2010 - ncbi.nlm.nih.gov
We tested whether it is possible to selectively block pain signals in the orofacial area by
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …
delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 …